Vertex Pharmaceuticals (VRTX) EBITDA (2009 - 2026)
Vertex Pharmaceuticals (VRTX) recorded EBITDA of $1.3 billion in Q2 2026, up 8.4% from $1.2 billion a year earlier and up 9.2% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) EBITDA (2009 - 2026) Analysis & Trends
On a TTM basis, Vertex Pharmaceuticals' EBITDA came in at $5 billion as of Jun 30, 2026, up 21.2% year-over-year; for FY2025, it was $4.38 billion.
- Annual EBITDA has a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
- Across earlier years, EBITDA came in at -$25.7 million in FY2024, $4.01 billion in FY2023 (-9.9%), $4.46 billion in FY2022 (+53.2%) and $2.91 billion in FY2021 (-2.0%).
- The Q2 2026 figure is the highest quarterly EBITDA in data going back to Q1 2009.
- On a year-over-year basis, EBITDA has increased for four consecutive quarters, with growth averaging 10.8% over the last seven quarters.
- Peak year-over-year performance for EBITDA in the last five years was growth of 76.0% in Q1 2026, against a decline of 43.1% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.19 billion (Q1 2026), $1.26 billion (Q4 2025) and $1.24 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Vertex Pharmaceuticals | 137.20 Bn | 109.19 Bn | 2.91 Bn | 782.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 782.10 Mn |
| Jun 30, 2026 | 1.30 Bn |
| Mar 31, 2026 | 1.19 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.24 Bn |
| Jun 30, 2025 | 1.20 Bn |
| Mar 31, 2025 | 678.50 Mn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 1.17 Bn |
| Jun 30, 2024 | -3.46 Bn |
| Mar 31, 2024 | 1.19 Bn |
| Dec 31, 2023 | 1.05 Bn |
| Sep 30, 2023 | 1.08 Bn |
| Jun 30, 2023 | 1.07 Bn |
| Mar 31, 2023 | 817.80 Mn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | 1.16 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 911.50 Mn |
API Access
Vertex Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();